Welcome to our dedicated page for VEECO INSTRUMENTS SEC filings (Ticker: VECO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Veeco Instruments Inc. filings document the regulatory record for a semiconductor process equipment manufacturer serving advanced semiconductor fabrication and packaging applications. Form 8-K reports cover operating and financial results, earnings-release exhibits, material-event disclosures and capital-structure information.
Proxy and annual meeting filings describe Veeco's governance framework, director elections, shareholder voting matters, stock incentive plan proposals, auditor ratification and advisory executive-compensation votes. The filings also provide formal disclosure context for the company's common stock, board oversight, material agreements and risks tied to semiconductor equipment markets and customer demand.
VEECO INSTRUMENTS INC (VECO) reported that CEO and director William John Miller sold a total of 200,000 shares of common stock on August 17, 2026 under a Rule 10b5-1 trading plan. The sales were executed in three tranches at weighted-average prices of $52.85, $54.07, and $54.49 per share, each representing multiple trades within stated price ranges.
VECO insider William J. Miller filed to sell 200,000 common shares under Rule 144. The shares are held at Wells Fargo Clearing Services and are listed on Nasdaq. The proposed sale has an aggregate market value of $10,831,362.85 based on the information provided.
The shares relate to an RSU grant dated 12/13/2017, with the same number of shares indicated as underlying the award. The filing also reports that in the past three months, Miller sold 50,000 VECO common shares on 06/02/2026 for total proceeds of $2,930,066.55.
VEECO INSTRUMENTS INC director Mary Jane Raymond reported a bona fide gift of 3,000 shares of Common Stock on 2026-08-13. The shares were donated to the Children's Hospital of Philadelphia and carried no stated sale price. After this charitable transfer, she directly holds 25,967 shares of Veeco common stock.
Veeco Instruments Inc. senior vice president and chief financial officer John P. Kiernan reported indirect sales of 35,000 shares of common stock on August 10, 2026 through a family trust. The shares were sold in multiple open-market transactions under a Rule 10b5-1 trading plan at weighted-average prices ranging from the high $49 area to the mid $54 level per share.
A shareholder of VECO, acting through Wells Fargo Clearing Services, has filed to sell up to 35,000 shares of VECO common stock on the Nasdaq on or after 08/10/2026. The filing lists an aggregate market value for the planned sale of $1,785,869.72.
The shares available for sale are tied to multiple RSU Grant awards from the issuer, with individual grants ranging from 329 to 22,539 common shares granted between 07/02/2023 and 03/13/2026.
Veeco Instruments Inc. reported Q2 2026 net sales of $193.5 million, up 16% from $166.1 million, driven by all end‑markets, notably Data Storage (up 80%) and Compound Semiconductor (up 45%). Net income was $11.9 million versus $11.7 million a year earlier, with diluted EPS of $0.18. Gross margin slipped to 39% from 41% on less favorable product mix and higher logistics and other costs.
For the first half of 2026, net sales were $351.8 million compared with $333.4 million, while net income was $11.5 million as operating expenses rose, including $3.5 million of merger costs. Cash and cash equivalents were $214.5 million and short‑term investments $214.9 million at June 30, 2026; long‑term debt consisted mainly of $230.0 million principal of 2.875% convertible notes due 2029, with no borrowings under the $250 million revolving credit facility.
The company continues to emphasize AI‑related semiconductor, compound semiconductor, and data‑storage opportunities and has $376.5 million of remaining performance obligations on longer‑duration contracts. A stock‑for‑stock merger with Axcelis Technologies remains pending, under which each Veeco share will convert into 0.3575 Axcelis shares upon closing, expected in the second half of 2026 subject to remaining regulatory approval in China.
Veeco Instruments reported Q2 2026 net sales of $193.5 million, up from $166.1 million a year earlier. GAAP net income was $11.9 million, or $0.18 per diluted share, compared with $11.7 million, or $0.20 per diluted share, in Q2 2025. On a non-GAAP basis, net income was $21.8 million, or $0.33 per diluted share, versus $21.5 million and $0.36 a year ago.
For the six months ended June 30, 2026, net sales were $351.8 million and GAAP net income was $11.5 million. As of June 30, 2026, cash and cash equivalents were $214.5 million, short-term investments were $214.9 million, long-term debt was $226.5 million, and stockholders’ equity totaled $902.8 million.
For Q3 2026, Veeco guides net sales to $200–$220 million, GAAP diluted EPS to $0.20–$0.35, and non-GAAP diluted EPS to $0.34–$0.49. Full-year 2026 guidance calls for net sales of $780–$810 million, GAAP diluted EPS of $0.78–$1.36, and non-GAAP diluted EPS of $1.02–$1.61. Management highlights AI-driven demand for its semiconductor process equipment and notes that its outlook is subject to risks, including completion of a pending merger with Axcelis and global trade conditions.
VEECO INSTRUMENTS INC senior vice president of global sales and service Susan Wilkerson reported an open-market sale of 15,505.6 shares of common stock on June 11, 2026. The shares were sold at an average price of $69.56, with individual sale prices ranging from $69.45 to $69.90 per share.
After this transaction, Wilkerson directly holds 27,467.925 shares of Veeco common stock. The filing notes that she can provide full details of the number of shares sold at each separate sale price upon request to regulators, the company, or its shareholders.
VECO: Form 144 filing reporting a planned sale of restricted/compensatory common stock and a recent sale. The filing lists restricted stock vesting events dated 03/13/2025, 03/14/2025, 03/17/2025, and 03/24/2025 with quantities 514, 1,929, 2,208, and 10,855 shares respectively. The filing also records a sale by Susan L. Wilkerson of 35,723 common shares on 05/26/2026 for $2,203,723.75. Broker information shown includes Fidelity Brokerage Services LLC and an NASDAQ designation.
VEECO INSTRUMENTS INC senior vice president of product line development, Adrian Devasahayam, reported an open-market sale of 10,000 shares of common stock at $65.00 per share. Following this sale, he directly holds 85,115.208 shares of Veeco common stock.